There are other incentives in life other than money.
No university or nonprofit has that kind of budget, and even if they did, they are unlikely to take on the risk of a failed drug.
Marketing spend is based on the idea you spend $X and get $X + Y back. This doesn't always work, but it's the general premise.
This means without marketing dollars they'd be making less money.
Drugs are things that people "need". If no drug companies advertised, people would still go to their doctors with problems, and doctors would still prescribe medication when necessary (you have some degree of advertising prompting doctor visits, but for the important stuff, and in a system where people are not afraid of the monetary cost of going to a doctor, they'll be going anyway).
However currently all drug manufacturers must advertise their products because their competitors advertise their competing products. Anyone who doesn't advertise will be left behind as patients request the drug that they saw on TV. No company wants to be the company that doesn't advertise.
Advertising makes advertising necessary. It's a sort of "Advertising Prisoners Dilemma": http://en.wikipedia.org/wiki/Prisoner's_dilemma#In_economics
One way to break this is to create laws that forbid advertising. Another is to allow the formation of cartels.
However, the cost of human trials are still a problem. Because of the costs, drug research to treat rare diseases aren't going to get funded by anyone.
So you're saying that drug advertising is pulling the wool over the eyes of the entire industry so that they give patients nothing more than placebos?
Most drugs, even those that offer a benefit over current therapies, don't sell themselves. Physicians need to learn about new drugs, have an opportunity to try them before you ever see widespread use.
For instance, with patents there is an incentive to find a solution first. This probably raises the cost of research because (a) pharmas spend more time researching alternative medicines with different compounds with the same effect as existing drugs simply to get around pre-existing patents and (b) pharmas spend more money to rush research to patent it first.
Also, if clinical trials are the problem, India appears to be willing to help.
For me the notion that someone can claim a right to a chemical compound that has positive effect on our bodies is absurd. It's like Einstein patenting e=mc^2 and asking nuclear power plants to pay him.
But there aren't other ways to fund drug research.
Yes there are; public money and normal sized salaries for scientists doing the public research for the public good. Granting monopolies to private corporations is hardly the only way to achieve things. Scientist's aren't in science for the money, science generally pays shit anyway; they're in it for other reasons.
Edit: the parent was originally a snarky one-liner "Yes there are"
There are legitimate problems with the current system, such as Pharma typically doesn't produce drugs for rare diseases - there just isn't enough money in the market to justify the lost opportunity costs. Publicly funded research is supposed to help those instances where the economic incentives aren't there.
This can lead to a perverse switch in motive. Instead of trying to help patients who legitimately need help to trying to get as many people to buy a drug as possible, regardless of need. But in case you haven't been paying attention - public funding for science isn't exactly growing. So if we want to see some of these next generation cancer drugs with small markets, you need to have the ability to charge large amounts.
But the public institutes just aren't equipped or financed well enough to handle it on their own.
I didn't say they did; I'm saying they should. Medicine as a business is immoral IMHO, and a good half of this county agrees with me. We want public healthcare, not private healthcare because money is a perverse incentive when it comes to health.
> But the public institutes just aren't equipped or financed well enough to handle it on their own.
Agreed, but they should be, and if we want to see a better healthcare system that does more for the general public rather than just the rich, they'll need to be. The free market is not the correct solution for healthcare/medicine. Medicine is a communal good and should be funded by and available to the whole community.
The current system has become a few spots, take a look at the debate about cherry-picking clinical trials to get new drugs approved, requirements for pre-registration and the non-functional oversight of the same ...
Perhaps trying new ways to fund drug research can be a part of revitalizing the system?
Seriously though I want to stab that guy. Maybe we should ask the scientists who put in the real work who they think should have access to the drugs.
And no, you can't pay for the costs with "satisfying intellectual curiosity"
When R&D budgets are no longer superseded by advertising budgets at pharmaceutical firms[1], I will start to find this line of argument compelling.
[1] http://www.sciencedaily.com/releases/2008/01/080105140107.ht...
The number there is from the figure here:
http://www.plosmedicine.org/article/info:doi/10.1371/journal...
How do you suggest intellectual curiosity be fulfilled with no money?
Drug development is fundamentally different from software. There is just no way to do it (either by public or private institutions) without a lot of money.
C'mon, mice can't cost that much.
And that doesn't even cover their plans for world domination.
Here's a link to Ohio State's per diem fee for mice: http://ular.osu.edu/rates-and-fees/ (It's around $1/day per cage there)
I think you can house up to 5 mice in a cage, and it wouldn't be uncommon for a reasonably sized lab to have a colony of around 200-300 mice. So you'd have maybe 75-100 cages (males you house at a lower rate). So your daily rate at OSU is on the order of $75-100. At other institutions, it can cost as much as $1 per mouse. And this is just for housing them. You start getting to real money, real fast.
A strongly decreased financial incentive is disincentive in a system where
1) Equipment and the necessities of life cost money, to say nothing of opportunity cost. Even the most ascetic lab rat can't eat good feelings and intellectual curiosity.
2) If you're looking to raise capital, E(ROI)>0 makes it 100x easier to raise 100x as much capital (perhaps this is exaggerating, but capital markets are MUCH larger than charity markets).
How much are they developing vs how much are they marketing? A lot of pharmacological studies are preformed by public universities and an insignificant amount of money that many think goes to "research" instead goes to "do you have <made_up_disease>? talk to your doctor about <our_new_drug?>" type commercials and other marketing.
> Try this for a comparison - Germany declares that all software sold in their country should be priced at $1 or less.
If that software will end up saving lives, then it should be sold for $1 or less and the government should develop/buy it/fund it.
Or how about another comparison. Open source software is priced at $0. Are people writing it? Why? They shouldn't according to your logic. So maybe someone will bother developing and researching life saving drugs without being granted monopoly on its distribution.
Let me know how much all those things cost.
Drug discovery (i.e. actual drugs; NOT just hits or lead molecules) is not as simple as pounding code on the couch in your jammies.
By the logic above, that should never happen.
The patent laws of the US are responsible for Bayer's business model, and in a lot of ways it's a good tradeoff. But it's not the only possible way to figure this stuff out, nor is the money the only possible incentive.
Anyway, it's not like Bayer wasn't aware of India's patent laws. They are still going to make billions on this drug, regardless of what India does, and they can spend that money bribing its government officials to change their patent laws. Don't worry, it'll all work out in the end.
While that is true about companies it is not true about people. There are numerous people who do research into specific medical conditions for reasons other than money. While I'm not saying Crowley didn't make a fair shake of money with his companies
http://en.wikipedia.org/wiki/John_Crowley_(biotech_executive...
There was a clear motivation to save his own, and other children's lives.
Would companies stop entirely or would not for profits arise in their place?
I think it's disingenuous to imply that there is no other way that medical research could ever happen.
One also has to examine the moral dilemma faced in this situation. Respect international intellectual property laws and quite literally allow millions to die OR "steal" the drug?
Now run the dilemma again but it's your own child.
Is it right? Would you do it?
Free software movements point to the probability that software would likely still exist in a world where it was declared that all software should be priced at ${arbitrary}.
I feel like the truth is far more nuanced than you're allowing for here. There's far more than money on the line and if I were the one dying of a $65,000/year cancer I'd also struggle to respect the international laws that were willing to consign me to death if the profit on the materials was in the 99% range.
No doubt that there are more incentives than just money, but you do realize that John Crowley is filthy stinking rich from the sales of his company to Genzyme, right?
Ha ha I appreciate your comment (and if it's sarcastic/funny it's actually hilarious)
But otherwise it's Ad hominem. I'm presenting him as a more nuanced human than just than just a guy who sold a company for $200M (http://newsok.com/novazyme-example-of-promise/article/275860...) and who's name gets floated as a possible (R) candidate (but who doesn't take on the role).
Perhaps he's one of the numerous Republicans who are dissatisfied with the entire radical wing. I don't know anything about that. Maybe the reason he repeatedly chose not to run or accept an appointment is he wasn't radical enough. After all, many do say that even Reagan wouldn't make it in today's Republican party.
Making a founder's share of $200M is probably fair payoff for saving all those children's lives (potentially ~10,000 cases in the USA)... especially when compared to a share of $1B for enabling the absoloute clusterfuck of idiocy that is TUMBLR.
Do Zuckerburg, Brin and Graham deserve the same derision for also being filthy stinking rich? Do all other motives get thrown out the window when they get a life changing payday?
Anyways, the sum of a person is more than their net worth and their political affiliations. I'm sure there are a handful of good people who are also Republicans.
I get where you're coming from, but I think what my point is is that you can have altruistic intentions and get filthy stinking rich in the process. In fact, you can be nothing but a greedy pig and still do good in the world.
The same applies for medicine. If you are with-holding drugs that can literally cure cancer but require you to cough up, say, $50,000, then I sincerely hope a hell exists for you because that is straight-up unapologetic evil.
If R&D is that expensive and you need to recoup costs, then the government should fund the research of such drugs.
No matter what the circumstances however, you don't get to restrict access to a drug that cures cancer based on financial capability and somehow take the moral high ground.
If someone has to take a drug for 3 years and pays 195,000 dollars, and there are tens of thousands of patients, they can certainly price it lower than that.
If the price per year is 1950 (3%) and a million people are using the drug, that that 1.95 billion dollars. Per Year.
If we were making the comparison to the software industry again we wouldn't make that same comparison, we would just have the people close up shop and start another startup when their product fails and they fail to pivot.
I guess the analogy just starts falling apart there.
After all, profits attract competition.
Obviously that isn't what you mean though, your talking about the competing from start to finish of a drug, well lets say a company invests in producing an equivalent cancer drug that doesn't infringe on the original patent. Now we have these two drugs that are effectively the same and they both compete and the price lowers down to the point were they are both making enough profit to support their business without over the top profits on that drug. Congratulations you've got to the point that the Indian government wants and all it took was a huge investment in an otherwise redundant drug.
Since the Indian government can't force the company to sell the drugs at the appropriate price they have to rely on the threat of letting other companies sell the drug at an even lower price and hope the company plays ball. The whole point behind intellectual property is that both the creator and the public benefit, if the public isn't benefiting then they will not respect intellectual property.
I think we have a lot of support for that here. :)
I'm all for any solution that doesn't require giving a cop access to my computer to enforce it.
It would be OK if this were known in advance; software developers could decide whether the absence of future German revenue meant they should (i) not develop a German version and/or (ii) not develop a product at all (as the non-German revenue would not be sufficient).
Changing the goalposts after development decisions are made is different.
lol - recursion.
Without this "privilege" a company has no incentive to develop anything new, leave alone anything that requires massive R&D investments. What India did is it effectively said that they don't want to participate in the development of new drugs, so their stance on this matter is frankly quite ludicrous.
Try this for a comparison - Germany declares that all software sold in their country should be priced at $1 or less. Would you still be talking about software companies being crybabies for objecting this? Doubt it.